Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Effect of Gestational Diabetes Mellitus and Hypercholesterolemia on Fetal Cardiovascular Disease Risk: The Role of Epigenetics

Author(s): Despina D. Briana* and Ariadne Malamitsi-Puchner

Volume 20, Issue 4, 2022

Published on: 04 August, 2022

Page: [379 - 380] Pages: 2

DOI: 10.2174/1570161120666220804090725

« Previous Next »
[1]
Espinoza C, Fuenzalida B, Leiva A. Increased fetal cardiovascular disease risk: Potential synergy between gestational diabetes mellitus and maternal hypercholesterolemia. Curr Vasc Pharmacol 2021; 19(6): 601-23.
[http://dx.doi.org/10.2174/1570161119666210423085407]
[2]
Paraskevas KI, Briana DD, Malamitsi-Puchner A, Mikhailidis DP. Fetal/infant origins of adult vascular disease. Curr Vasc Pharmacol 2020; 18(4): 418-20.
[http://dx.doi.org/10.2174/1570161118999200304123040]
[3]
Briana DD, Germanou K, Boutsikou M, et al. Potential prognostic biomarkers of cardiovascular disease in fetal macrosomia: The impact of gestational diabetes. J Matern Fetal Neonatal Med 2018; 31(7): 895-900.
[http://dx.doi.org/10.1080/14767058.2017.1300651]
[4]
Papathanasiou AE, Briana DD, Gavrili S, et al. Cord blood fatty acid-binding protein-4 levels are upregulated at both ends of the birthweight spectrum. Acta Paediatr 2019; 108(11): 2083-8.
[http://dx.doi.org/10.1111/apa.14826]
[5]
Krause B, Sobrevia L, Casanello P. Epigenetics: New concepts of old phenomena in vascular physiology. Curr Vasc Pharmacol 2009; 7(4): 513-20.
[http://dx.doi.org/10.2174/157016109789043883]
[6]
Shiau S, Wang L, Liu H, et al. Prenatal gestational diabetes mellitus exposure and accelerated offspring DNA methylation age in early childhood. Epigenetics 2021; 16(2): 186-95.
[http://dx.doi.org/10.1080/15592294.2020.1790924]
[7]
Martino F, Magenta A, Pannarale G, et al. Epigenetics and cardiovascular risk in childhood. J Cardiovasc Med (Hagerstown) 2016; 17(8): 539-46.
[http://dx.doi.org/10.2459/JCM.00000000000000334]
[8]
de Nigris F, Cacciatore F, Mancini FP, et al. Epigenetic hallmarks of fetal early atherosclerotic lesions in humans. JAMA Cardiol 2018; 3(12): 1184-91.
[http://dx.doi.org/10.1001/jamacardio.2018.3546]
[9]
Contreras-Duarte S, Carvajal L, Fuenzalida B, Cantin C, Sobrevia L, Leiva A. Maternal dyslipidaemia in pregnancy with gestational diabetes mellitus: Possible impact on foetoplacental vascular function and lipoproteins in the neonatal circulation. Curr Vasc Pharmacol 2019; 17(1): 52-71.
[10]
Larsen TD, Sabey KH, Knutson AJ, et al. Diabetic pregnancy and maternal high-fat diet impair mitochondrial dynamism in the developing fetal rat heart by sex-specific mechanisms. Int J Mol Sci 2019; 20(12): 3090.
[http://dx.doi.org/10.3390/ijms20123090]
[11]
Preston CC, Larsen TD, Eclov JA, et al. Maternal high fat diet and diabetes disrupts transcriptomic pathways that regulate cardiac metabolism and cell fate in newborn rat hearts. Front Endocrinol (Lausanne) 2020; 11: 570846.
[http://dx.doi.org/10.3389/fendo.2020.570846]
[12]
Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of maternal obesity and gestational diabetes mellitus on the placenta: Current knowledge and targets for therapeutic interventions. Curr Vasc Pharmacol 2021; 19(2): 176-92.

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy